Jesús Martin-Garcia: CEO of GeNeuro

from BioBoss · host Jesús Martin-Garcia

Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.

Episode metadata supplied by the publisher feed · Published Sep 19, 2022

Embed this episode

Attribution link and audio player

Ready to play

Jesús Martin-Garcia: CEO of GeNeuro

0:00 42:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 42 minutes long.

When was this BioBoss episode published?

This episode was published on September 19, 2022.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!